Matches in Nanopublications for { ?s ?p "[Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_assertion description "[Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP30565.RAYhaZyDAmoRQi2MN9WlgsdFpyZVnfI6Lht4GQ91kk0yc130_provenance.
- assertion description "[Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP949703.RAS1kfiwatd0Ni6WrMimHbYGTdWH5WaV7I6XFQG0rIx1E130_assertion description "[Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949703.RAS1kfiwatd0Ni6WrMimHbYGTdWH5WaV7I6XFQG0rIx1E130_provenance.
- NP949706.RATYRueOdQzhtFbY3lL3W5509dxIe4SbOA07ZBAF9zSoA130_assertion description "[Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949706.RATYRueOdQzhtFbY3lL3W5509dxIe4SbOA07ZBAF9zSoA130_provenance.
- NP30564.RAlxvqTXM_f4E-tgZCEanloihrcVJAAQ9Wli7mjOtla0s130_assertion description "[Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP30564.RAlxvqTXM_f4E-tgZCEanloihrcVJAAQ9Wli7mjOtla0s130_provenance.